The Structure of Arylamine N-acetyltransferase from Mycobacterium smegmatis—An Enzyme which Inactivates the Anti-tubercular Drug, Isoniazid (original) (raw)

Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis

Khalid Yousuf

Biomedicine & Pharmacotherapy, 2017

View PDFchevron_right

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

Kai Johnson

Proceedings of the National Academy of Sciences, 2013

View PDFchevron_right

Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology

Celia Goulding

Infectious disorders drug targets, 2012

View PDFchevron_right

Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity

Areej Abuhammad

Acta crystallographica. Section D, Biological crystallography, 2013

View PDFchevron_right

Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets

Helen Birch

2007

View PDFchevron_right

Challenges in Drug Discovery against Tuberculosis

MANISH DWIVEDI

Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex, 2021

View PDFchevron_right

Arabinosyltransferase C enzyme of Mycobacterium tuberculosis, a potential drug target: An insight from molecular docking study

Nisha Das

Heliyon

View PDFchevron_right

Challenges in the development of drugs for the treatment of tuberculosis

Mazhar Ulislam

The Brazilian Journal of Infectious Diseases, 2013

View PDFchevron_right

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment

MUTIARA SARAGIH

Pharmaceutics, 2021

View PDFchevron_right

Increasing the structural coverage of tuberculosis drug targets

Matthew Clifton, Alberto Napuli, Garry Buchko

Tuberculosis, 2014

View PDFchevron_right

The potential impact of structural genomics on tuberculosis drug discovery

Vickery Arcus

Drug Discovery Today, 2006

View PDFchevron_right

Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives

Dr Ashok Rattan

Emerging Infectious Diseases, 1998

View PDFchevron_right

Advances in Mycobacterium tuberculosis structural genomics: investigating potential chinks in the armor of a deadly pathogen

Celia Goulding

Infectious disorders drug targets, 2009

View PDFchevron_right

Fighting tuberculosis: An old disease with new challenges

Rama P Tripathi

Medicinal research …, 2005

View PDFchevron_right

Nonprotein Structures from Mycobacteria: Emerging Actors for Tuberculosis Control

Luz M López-Marín

Clinical and Developmental Immunology, 2012

View PDFchevron_right

Perspectives Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives

Ashok Rattan

2013

View PDFchevron_right

Attack on the Scourge of Tuberculosis: Patented Drug Targets

Yogendra Singh

Recent Patents on Anti-Infective Drug Discovery, 2006

View PDFchevron_right

Novel targets for tuberculosis drug discovery

Melvin Spigelman

Current opinion in pharmacology, 2006

View PDFchevron_right

Structural variability of Mycobacterium tuberculosis SSB and susceptibility to inhibition

Sibi Narayanan

Current Science

View PDFchevron_right

Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis

Mark Hickey, Kristine Guinn

Plos One, 2013

View PDFchevron_right

Novel drug target strategies against Mycobacterium tuberculosis Curr Op Microbiology 2008

Maria Sol Diaz

View PDFchevron_right

New drug targets for Mycobacterium tuberculosis

Pappi chusa

The Indian Journal of Medical Research

View PDFchevron_right

Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach

Mohamad S sabbah

Frontiers in Pharmacology, 2017

View PDFchevron_right

The crystal structure of Rv1347c, a putative antibiotic resistance protein from Mycobacterium tuberculosis, reveals a GCN5-related fold and suggests an alternative …

Clyde Smith

Journal of Biological …, 2005

View PDFchevron_right

The crystal structure of Mycobacterium tuberculosis NrdH at 0.87 Å suggests a possible mode of its activity

Shekhar Mande

View PDFchevron_right

Structural basis ofMycobacterium tuberculosistranscription and transcription inhibition

Nancy Connell

2017

View PDFchevron_right

X-Ray Crystal Structure of Mycobacterium tuberculosis β-Ketoacyl Acyl Carrier Protein Synthase II (mtKasB)

Sudharsan Sridharan

Journal of Molecular Biology, 2007

View PDFchevron_right

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs

Pedro Almeida da Silva

Journal of Antimicrobial Chemotherapy, 2011

View PDFchevron_right

Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA

Daniel Anderson

Biophysical Chemistry, 2003

View PDFchevron_right